Pharvaris N.V. Files Routine 6-K Report
Ticker: PHVS · Form: 6-K · Filed: Sep 8, 2025 · CIK: 1830487
| Field | Detail |
|---|---|
| Company | Pharvaris N.V. (PHVS) |
| Form Type | 6-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Pharvaris N.V. filed a standard 6-K, no new info.
AI Summary
Pharvaris N.V. filed a Form 6-K on September 8, 2025, reporting for the month of September 2025. The company, previously known as Pharvaris, B.V., is a foreign private issuer incorporated in P7 and headquartered in Leiden, The Netherlands. This filing is routine and does not appear to contain specific financial updates or material events.
Why It Matters
This filing indicates Pharvaris N.V. is fulfilling its reporting obligations as a foreign private issuer. It does not contain new financial information or material business developments.
Risk Assessment
Risk Level: low — This is a routine filing that does not disclose new material information or financial performance.
Key Players & Entities
- Pharvaris N.V. (company) — Registrant
- Pharvaris, B.V. (company) — Former company name
- 001-40010 (other) — SEC File Number
- 2834 (other) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer may be required to disclose or make public in its home country.
When was Pharvaris N.V. previously known as?
Pharvaris N.V. was previously known as Pharvaris, B.V., with a date of name change on October 29, 2020.
Where is Pharvaris N.V. headquartered?
Pharvaris N.V. is headquartered in Leiden, The Netherlands, with its principal executive office at Emmy Noetherweg 2, 2333 BK Leiden.
What is Pharvaris N.V.'s Standard Industrial Classification code?
Pharvaris N.V.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Does this filing indicate any new financial results or material events?
No, this Form 6-K is a routine report for the month of September 2025 and does not appear to contain specific financial updates or disclose material events.
Filing Stats: 506 words · 2 min read · ~2 pages · Grade level 12.7 · Accepted 2025-09-08 16:51:30
Filing Documents
- d19198d6k.htm (6-K) — 13KB
- d19198dex991.htm (EX-99.1) — 87KB
- 0001193125-25-198423.txt ( ) — 101KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PHARVARIS N.V. Date: September 8, 2025 By: /s/ Berndt Modig Name: Berndt Modig Title: Chief Executive Officer